CEO of $VRNS Makes Insider Purchase of 26,725 Shares

Recently, the CEO of the company VRNS, Yakov Faitelson, made a significant investment by acquiring 26,725 shares of $VRNS stock on February 9, 2026, totaling approximately $598,907. This transaction, unveiled by Quiver Quantitative through a recent SEC filing, boosted Faitelson’s holdings by approximately 1.2%, bringing his total shares of $VRNS stock to 2,185,387.

In the past six months, internal members of $VRNS have engaged in several trades on the open market, with a total of eight transactions. Out of these, there have been four purchases and four sales. The Chief Financial Officer and Chief Operating Officer, Guy Melamed, has executed four sales amounting to 58,497 shares valued at around $3,405,081. Additionally, Avrohom J. Kess purchased 17,800 shares for an estimated $396,762, while John J Jr. Gavin acquired 5,000 shares for approximately $112,700. Furthermore, David Bass, the Executive Vice President of Engineering and Chief Technology Officer, procured 2,980 shares for an estimated $69,940.

In terms of hedge fund activities, there have been notable changes in $VRNS stock. 176 institutional investors have bolstered their portfolios by adding shares of $VRNS, whereas 187 decreased their positions. Noteworthy adjustments include Alyeska Investment Group, L.P. removing 2,113,314 shares (-96.2%) from their holdings in the third quarter of 2025, valued at approximately $121,452,155. Conversely, Cadian Capital Management, LP added 1,816,100 shares (+inf%) to their portfolio during the same period, totaling an estimated $104,371,267. Additionally, over the course of the fourth quarter of 2025, Goldman Sachs Group Inc. removed 1,733,219 shares (-58.4%) from their portfolio, amounting to approximately $56,849,583.

Despite these internal and external fluctuations, $VRNS reported revenues of $173.4M in the fourth quarter of 2025, reflecting a 9.37% increase compared to the corresponding period in the previous year. Wall Street analysts have closely monitored $VRNS, issuing several reports and ratings. Notably, 11 firms have issued buy ratings on the stock, providing optimistic outlooks. Needham issued a “Buy” rating on February 4, 2026, while Barclays and Piper Sandler both issued “Overweight” ratings on January 5, 2026. Moreover, RBC Capital, Cantor Fitzgerald, and Susquehanna have also issued favorable ratings in recent months.

Moreover, analyzing the projections, multiple analysts have put forth price targets for $VRNS in the last six months, with a median target of $41.0. Notable price targets have been set by analysts such as Rudy Kessinger from DA Davidson, Fatima Boolani from Citigroup, and Dan Ives from Wedbush, among others, highlighting varying perspectives on the company’s future performance.

It is essential to note that the information provided in this article does not constitute financial advice, and readers are encouraged to refer to Quiver Quantitative’s disclaimers for further information.